Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Progesterone 200 mg Soft Capsule vs Utrogestan®
NCT05125640Phase 1Completed
- Sponsor
- Farmak
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of progesterone in Progesterone deficiency (2 arms), sponsored by Farmak. Primary endpoints: Maximum plasma concentration and Area under the plasma concentration-time curve from time zero to the last measurable concentration. Started Dec 2019; status: completed.
02
Drugs
progesterone
03
Conditions
Progesterone deficiency
Beyond the preview
Go deeper on NCT05125640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125640.